Clinical Trials

Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors

Link :
Status : CLOSED
Population : Synovial Sarcoma
Description : ACT in SS
PI : A. Razak
J. Noujaim
Centers Opened : Princess Margaret Cancer Centre
Hôpital Maisonneuve Rosemont
Phase : II
IIST/Pharma : Pharma